Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioventus Inc. - Class A Common Stock (NQ:BVS)

6.400 -0.070 (-1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bioventus Inc. - Class A Common Stock

< Previous 1 2 3 4 5 6 7 Next >
Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Earnings Preview
 
Via Benzinga
Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023
From Bioventus, Inc.
Via GlobeNewswire
Recap: Bioventus Q1 Earnings
 
Via Benzinga
Earnings Preview: Bioventus
 
Via Benzinga
Preview: Bioventus's Earnings
 
Via Benzinga
Earnings Preview: Bioventus
 
Via Benzinga
Over $1M Bet On Bioventus? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 200 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Why Bluejay Diagnostics Shares Are Trading Lower By 12%; Here Are 20 Stocks Moving Premarket
Gainers Visionary Education Technology Holdings Group Inc. (NASDAQ: VEDU) shares rose 85.8% to $0.7985 in pre-market trading. 
Via Benzinga
Barnwell Industries And 3 Other Stocks Under $3 Insiders Are Aggressively Buying
The Dow Jones closed higher by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 250 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Over $2.5M Bet On This Healthcare Stock? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
The Dow Jones closed lower by over 200 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... 
Via Benzinga
Bioventus Completes Divestiture of its Wound Business
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Reports First Quarter Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Reschedules Earnings Call to May 16, 2023; Files for Extension to File Form 10-Q for the Period Ended April 1, 2023
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Announces Divestiture of its Wound Business
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report First Quarter of Fiscal Year 2023 Financial Results on May 11, 2023
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Inc. (NASDAQ:BVS) Long Term Investor Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 04/25/2023 -- An investigation was announced for long-term investors in shares of Bioventus Inc. (NASDAQ:BVS) concerning potential breaches of fiduciary duties by certain... 
Via SBWire
Bioventus Announces CEO Leadership Change
From Bioventus, Inc.
Via GlobeNewswire
Last Day Of Q1
Wall Street bonuses fell 26% last year. This was the biggest drop since 2008. Wall Street is estimated to be responsible for 16% of all economic activity in NYC. Wild nights out for ibankers slowing... 
Via Benzinga
Bioventus Reports Fourth Quarter and Full-Year 2022 Financial Results
From Bioventus, Inc.
Via GlobeNewswire
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility
From Bioventus, Inc.
Via GlobeNewswire
Bioventus Reschedules Reporting of Fourth Quarter Fiscal Year 2022 Financial Results to March 31, 2023
From Bioventus, Inc.
Via GlobeNewswire
Bioventus to Report Fourth Quarter of Fiscal Year 2022 Financial Results on March 30, 2023
From Bioventus, Inc.
Via GlobeNewswire
Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Bioventus Inc. (BVS) Investors of Class Action and Last Few Hours to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
BVS DEADLINE TOMORROW: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Bioventus Inc. Investors with Losses to Secure Counsel Before Important March 13 Deadline in Securities Class Action - BVS
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Lawsuit
BIOVENTUS DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bioventus Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.